The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens
2011-01-01 Benevolo, G; Larocca, A; Gentile, M; Pregno, P; Gay, F; Botto, B; Frairia, C; Evangelista, A; Morabito, F; Boccadoro, M; Vitolo, U; Palumbo, A.
Immunoglobulin heavy chain variable region gene (IGHV) and prediction of time to first treatment (TTFT) in patients with chronic lymphocytic leukemia (CLL): Mutational load or mutational status? Analysis of 1003 cases.
2018-01-01 Morabito, F; Shanafelt, Td; Gentile, M; Reda, G; Mauro, Fr; Rossi, D; Di Renzo, N; Molica, S; Angrilli, F; Chiarenza, A; Cutrona, G; Chaffee, Kg; Parikh, Sa; Tripepi, G; D'Arrigo, G; Vigna, E; Recchia, Ag; Cortelezzi, A; Gaidano, G; Di Raimondo, F; Fais, F; Foà, R; Neri, A; Ferrarini, M.
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression
2020-01-01 Tissino, E; Pozzo, F; Benedetti, D; Caldana, C; Bittolo, T; Rossi, Fm; Bomben, R; Nanni, P; Chivilò, H; Cattarossi, I; Zaina, E; Norris, K; Polesel, J; Gentile, M; Tripepi, G; Moia, R; Santinelli, E; Innocenti, I; Olivieri, J; D'Arena, G; Laurenti, L; Zaja, F; Pozzato, G; Chiarenza, A; Di Raimondo, F; Rossi, D; Pepper, C; Hartmann, Tn; Gaidano, G; Del Poeta, G; Gattei, V; Zucchetto, A.
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice.
2018-01-01 Breccia, M; Abruzzese, E; Castagnetti, F; Bonifacio, M; Gangemi, D; Sorà, F; Iurlo, A; Luciano, L; Gozzini, A; Gentile, M; Bocchia, M; Luzi, D; Maggi, A; Sgherza, N; Isidori, A; Crugnola, M; Pregno, P; Scortechini, Ar; Capodanno, I; Pizzuti, M; Foà, R.
Do Biologic Parameters Affect the Time to First Treatment of Clinical Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia Rai Stage 0? Results of a Prospective Analysis
2014-01-01 Molica, S; Giannarelli, D; Levato, L; Gentile, M; Mirabelli, R; Morabito, F.
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases
2014-01-01 Gentile, M; Mauro, Fr; Rossi, D; Vincelli, I; Tripepi, G; Recchia, Ag; De Stefano, L; Campanelli, M; Giannarelli, D; Bossio, S; Morabito, L; Vigna, E; Gaidano, G; Foà, R; Morabito, F.
Emerging biological insights and novel treatment strategies in multiple myeloma.
2012-01-01 Gentile, M; Recchia, Ag; Mazzone, C; Morabito, F.
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment
2018-01-01 Gentile, M; Shanafelt, Td; Mauro, Fr; Reda, G; Rossi, D; Laurenti, L; Del Principe, Mi; Cutrona, G; Angeletti, I; Coscia, M; Herishanu, Y; Chiarenza, A; Molica, S; Ciolli, S; Goldschmidt, N; Angrilli, F; Giordano, A; Rago, A; Bairey, O; Tripepi, G; Chaffee, Kg; Sameer, Pa; Vigna, E; Zirlik, K; Shvidel, L; Innocenti, I; Recchia, Ag; Di Raimondo, F; Del Poeta, G; Cortelezzi, A; Neri, A; Ferrarini, M; Gaidano, G; Kay, Ne; Polliack, A; Foà, R; Morabito, F
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab
2020-01-01 Gentile, M; Martino, Ea; Visentin, A; Coscia, M; Reda, G; Sportoletti, P; Mauro, Fr; Laurenti, L; Varettoni, M; Murru, R; Chiarenza, A; Vigna, E; Mendicino, F; Lucia, E; Bossio, S; Recchia, Ag; Moia, R; Pietrasanta, D; Loseto, G; Consoli, U; Scortechini, I; Rossi, Fm; Zucchetto, A; Al-Janazreh, H; Vitale, C; Tripepi, G; D'Arrigo, G; Angeletti, I; Bomben, R; Neri, A; Cutrona, G; Fronza, G; Di Raimondo, F; Gaidano, G; Cuneo, A; Foà, R; Ferrarini, M; Trentin, L; Gattei, V; Morabito, F.
Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL).
2012-01-01 Molica, S; Digiesi, G; Antenucci, A; Levato, L; Mirabelli, R; Molica, M; Gentile, M; Giannarelli, D; Sperduti, I; Morabito, F; Conti, L.
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia.
2013-01-01 Fabris, S; Mosca, L; Cutrona, G; Lionetti, M; Agnelli, L; Ciceri, G; Barbieri, M; Maura, F; Matis, S; Colombo, M; Gentile, M; Recchia, Ag; Anna Pesce, E; Di Raimondo, F; Musolino, C; Gobbi, M; Di Renzo, N; Mauro, Fr; Brugiatelli, M; Ilariucci, F; Lipari, Mg; Angrilli, F; Consoli, U; Fragasso, A; Molica, S; Festini, G; Vincelli, I; Cortelezzi, A; Federico, M; Morabito, F; Ferrarini, M; Neri, A.
Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis.
2019-01-01 Bonello, F; Pulini, S; Ballanti, S; Gentile, M; Spada, S; Annibali, O; Omedé, P; Ronconi, S; Cangialosi, C; Podda, L; Palmas, A; Malfitano, A; Rivoli, G; Belotti, A; Ciambelli, F; Vincelli, Id; Cafro, Am; Innao, V; Palumbo, A; Sonneveld, P; Spencer, A; Hájek, R; Boccadoro, M; Gay, F.
Perspectives in the treatment of multiple myeloma.
2013-01-01 Gentile, M; Recchia, Ag; Mazzone, C; Lucia, E; Vigna, E; Morabito, F.
Rituximab for the treatment of patients with chronic lymphocytic leukemia.
2010-01-01 Gentile, M; Vigna, E; Mazzone, C; Lucia, E; Recchia, A; Morabito, L; Bisconte, M; Gentile, C; Morabito, F.
Long-Term Results in Multiple Myeloma After High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs
2014-01-01 Martino, M; Postorino, M; Gallo, Ga; Messina, G; Neri, S; Piro, E; Gentile, M; Moscato, T; Monteleone, R; Fedele, R; Mazzone, C; Console, G; Penna, G; Alati, C; Vincelli, Id; Irrera, G; Musolino, C; Ronco, F; Molica, S; Morabito, F.
The role of tandem stem cell transplantation for multiple myeloma patients.
2016-01-01 Martino, M; Recchia, Ag; Fedele, R; Neri, S; Vincelli, Id; Moscato, T; Gentile, M; Morabito, F.
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant
2020-01-01 Martino, M; Gori, M; Tripepi, G; Recchia, Ag; Cimminiello, M; Provenzano, Pf; Naso, V; Ferreri, A; Moscato, T; Console, G; Loteta, B; Gallo, Ga; Gentile, M; Innao, V; Rossi, M; Morabito, A; Vincelli, Id; Mannina, D; Pitino, A.
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
2013-01-01 Morabito, F; Mosca, L; Cutrona, G; Agnelli, L; Tuana, G; Ferracin, M; Zagatti, B; Lionetti, M; Fabris, S; Maura, F; Matis, S; Gentile, M; Vigna, E; Colombo, M; Massucco, C; Recchia, Ag; Bossio, S; De Stefano, L; Ilariucci, F; Musolino, C; Molica, S; Di Raimondo, F; Cortelezzi, A; Tassone, P; Negrini, M; Monti, S; Rossi, D; Gaidano, G; Ferrarini, M; Neri, A.
Ixazomib for the treatment of multiple myeloma
2015-01-01 Gentile, M; Offidani, M; Vigna, E; Corvatta, L; Recchia, Ag; Morabito, L; Morabito, F; Gentili, S.
Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia
2014-01-01 Hoxha, M; Fabris, S; Agnelli, L; Bollati, V; Cutrona, G; Matis, S; Recchia, Ag; Gentile, M; Cortelezzi, A; Morabito, F; Bertazzi, Pa; Ferrarini, M; Neri, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens | 1-gen-2011 | Benevolo, G; Larocca, A; Gentile, M; Pregno, P; Gay, F; Botto, B; Frairia, C; Evangelista, A; Morabito, F; Boccadoro, M; Vitolo, U; Palumbo, A. | |
| Immunoglobulin heavy chain variable region gene (IGHV) and prediction of time to first treatment (TTFT) in patients with chronic lymphocytic leukemia (CLL): Mutational load or mutational status? Analysis of 1003 cases. | 1-gen-2018 | Morabito, F; Shanafelt, Td; Gentile, M; Reda, G; Mauro, Fr; Rossi, D; Di Renzo, N; Molica, S; Angrilli, F; Chiarenza, A; Cutrona, G; Chaffee, Kg; Parikh, Sa; Tripepi, G; D'Arrigo, G; Vigna, E; Recchia, Ag; Cortelezzi, A; Gaidano, G; Di Raimondo, F; Fais, F; Foà, R; Neri, A; Ferrarini, M. | |
| CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression | 1-gen-2020 | Tissino, E; Pozzo, F; Benedetti, D; Caldana, C; Bittolo, T; Rossi, Fm; Bomben, R; Nanni, P; Chivilò, H; Cattarossi, I; Zaina, E; Norris, K; Polesel, J; Gentile, M; Tripepi, G; Moia, R; Santinelli, E; Innocenti, I; Olivieri, J; D'Arena, G; Laurenti, L; Zaja, F; Pozzato, G; Chiarenza, A; Di Raimondo, F; Rossi, D; Pepper, C; Hartmann, Tn; Gaidano, G; Del Poeta, G; Gattei, V; Zucchetto, A. | |
| Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice. | 1-gen-2018 | Breccia, M; Abruzzese, E; Castagnetti, F; Bonifacio, M; Gangemi, D; Sorà, F; Iurlo, A; Luciano, L; Gozzini, A; Gentile, M; Bocchia, M; Luzi, D; Maggi, A; Sgherza, N; Isidori, A; Crugnola, M; Pregno, P; Scortechini, Ar; Capodanno, I; Pizzuti, M; Foà, R. | |
| Do Biologic Parameters Affect the Time to First Treatment of Clinical Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia Rai Stage 0? Results of a Prospective Analysis | 1-gen-2014 | Molica, S; Giannarelli, D; Levato, L; Gentile, M; Mirabelli, R; Morabito, F. | |
| Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases | 1-gen-2014 | Gentile, M; Mauro, Fr; Rossi, D; Vincelli, I; Tripepi, G; Recchia, Ag; De Stefano, L; Campanelli, M; Giannarelli, D; Bossio, S; Morabito, L; Vigna, E; Gaidano, G; Foà, R; Morabito, F. | |
| Emerging biological insights and novel treatment strategies in multiple myeloma. | 1-gen-2012 | Gentile, M; Recchia, Ag; Mazzone, C; Morabito, F. | |
| Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment | 1-gen-2018 | Gentile, M; Shanafelt, Td; Mauro, Fr; Reda, G; Rossi, D; Laurenti, L; Del Principe, Mi; Cutrona, G; Angeletti, I; Coscia, M; Herishanu, Y; Chiarenza, A; Molica, S; Ciolli, S; Goldschmidt, N; Angrilli, F; Giordano, A; Rago, A; Bairey, O; Tripepi, G; Chaffee, Kg; Sameer, Pa; Vigna, E; Zirlik, K; Shvidel, L; Innocenti, I; Recchia, Ag; Di Raimondo, F; Del Poeta, G; Cortelezzi, A; Neri, A; Ferrarini, M; Gaidano, G; Kay, Ne; Polliack, A; Foà, R; Morabito, F | |
| Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab | 1-gen-2020 | Gentile, M; Martino, Ea; Visentin, A; Coscia, M; Reda, G; Sportoletti, P; Mauro, Fr; Laurenti, L; Varettoni, M; Murru, R; Chiarenza, A; Vigna, E; Mendicino, F; Lucia, E; Bossio, S; Recchia, Ag; Moia, R; Pietrasanta, D; Loseto, G; Consoli, U; Scortechini, I; Rossi, Fm; Zucchetto, A; Al-Janazreh, H; Vitale, C; Tripepi, G; D'Arrigo, G; Angeletti, I; Bomben, R; Neri, A; Cutrona, G; Fronza, G; Di Raimondo, F; Gaidano, G; Cuneo, A; Foà, R; Ferrarini, M; Trentin, L; Gattei, V; Morabito, F. | |
| Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL). | 1-gen-2012 | Molica, S; Digiesi, G; Antenucci, A; Levato, L; Mirabelli, R; Molica, M; Gentile, M; Giannarelli, D; Sperduti, I; Morabito, F; Conti, L. | |
| Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia. | 1-gen-2013 | Fabris, S; Mosca, L; Cutrona, G; Lionetti, M; Agnelli, L; Ciceri, G; Barbieri, M; Maura, F; Matis, S; Colombo, M; Gentile, M; Recchia, Ag; Anna Pesce, E; Di Raimondo, F; Musolino, C; Gobbi, M; Di Renzo, N; Mauro, Fr; Brugiatelli, M; Ilariucci, F; Lipari, Mg; Angrilli, F; Consoli, U; Fragasso, A; Molica, S; Festini, G; Vincelli, I; Cortelezzi, A; Federico, M; Morabito, F; Ferrarini, M; Neri, A. | |
| Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis. | 1-gen-2019 | Bonello, F; Pulini, S; Ballanti, S; Gentile, M; Spada, S; Annibali, O; Omedé, P; Ronconi, S; Cangialosi, C; Podda, L; Palmas, A; Malfitano, A; Rivoli, G; Belotti, A; Ciambelli, F; Vincelli, Id; Cafro, Am; Innao, V; Palumbo, A; Sonneveld, P; Spencer, A; Hájek, R; Boccadoro, M; Gay, F. | |
| Perspectives in the treatment of multiple myeloma. | 1-gen-2013 | Gentile, M; Recchia, Ag; Mazzone, C; Lucia, E; Vigna, E; Morabito, F. | |
| Rituximab for the treatment of patients with chronic lymphocytic leukemia. | 1-gen-2010 | Gentile, M; Vigna, E; Mazzone, C; Lucia, E; Recchia, A; Morabito, L; Bisconte, M; Gentile, C; Morabito, F. | |
| Long-Term Results in Multiple Myeloma After High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs | 1-gen-2014 | Martino, M; Postorino, M; Gallo, Ga; Messina, G; Neri, S; Piro, E; Gentile, M; Moscato, T; Monteleone, R; Fedele, R; Mazzone, C; Console, G; Penna, G; Alati, C; Vincelli, Id; Irrera, G; Musolino, C; Ronco, F; Molica, S; Morabito, F. | |
| The role of tandem stem cell transplantation for multiple myeloma patients. | 1-gen-2016 | Martino, M; Recchia, Ag; Fedele, R; Neri, S; Vincelli, Id; Moscato, T; Gentile, M; Morabito, F. | |
| A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant | 1-gen-2020 | Martino, M; Gori, M; Tripepi, G; Recchia, Ag; Cimminiello, M; Provenzano, Pf; Naso, V; Ferreri, A; Moscato, T; Console, G; Loteta, B; Gallo, Ga; Gentile, M; Innao, V; Rossi, M; Morabito, A; Vincelli, Id; Mannina, D; Pitino, A. | |
| Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features. | 1-gen-2013 | Morabito, F; Mosca, L; Cutrona, G; Agnelli, L; Tuana, G; Ferracin, M; Zagatti, B; Lionetti, M; Fabris, S; Maura, F; Matis, S; Gentile, M; Vigna, E; Colombo, M; Massucco, C; Recchia, Ag; Bossio, S; De Stefano, L; Ilariucci, F; Musolino, C; Molica, S; Di Raimondo, F; Cortelezzi, A; Tassone, P; Negrini, M; Monti, S; Rossi, D; Gaidano, G; Ferrarini, M; Neri, A. | |
| Ixazomib for the treatment of multiple myeloma | 1-gen-2015 | Gentile, M; Offidani, M; Vigna, E; Corvatta, L; Recchia, Ag; Morabito, L; Morabito, F; Gentili, S. | |
| Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia | 1-gen-2014 | Hoxha, M; Fabris, S; Agnelli, L; Bollati, V; Cutrona, G; Matis, S; Recchia, Ag; Gentile, M; Cortelezzi, A; Morabito, F; Bertazzi, Pa; Ferrarini, M; Neri, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista40401
- 2 Contributo in Volume2
Data di pubblicazione
- In corso di stampa37
- 2020 - 202713203
- 2010 - 201915036
- 2000 - 20097892
- 1990 - 19993088
- 1980 - 19891038
- 1971 - 1979109
Editore
- Society for information display2
- TAYLOR & FRANCIS LTD, 4 PARK SQUA...2
- "Il pensiero scientifico" Editore1
- American Physical Society1
- Athens Institute for Education an...1
- Deputazione Storia Patria per la ...1
- Edizioni Scientifiche Calabresi1
- ELSEVIER SCIENCE BV, PO BOX 211, ...1
- ETS1
- Geological Society of America Spe...1
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS498
- PHYSICS LETTERS. SECTION B469
- THE EUROPEAN PHYSICAL JOURNAL. C,...397
- PHYSICAL REVIEW LETTERS272
- MOLECULES176
- PHYSICAL REVIEW D173
- BOLLETTINO FILOSOFICO168
- INTERNATIONAL JOURNAL OF MOLECULA...166
- APPLIED SCIENCES165
- FILOLOGIA ANTICA E MODERNA151
Serie
- ATINER'S CONFERENCE PAPER SERIES1
- INTERNATIONAL REVIEW OF NEUROBIOLOGY1
Keyword
- Humans268
- COVID-19164
- Italy154
- Calabria113
- Hadron-Hadron Scattering111
- Female110
- High Energy Physics - Experiment106
- Palladium105
- Hadron-Hadron scattering (experim...95
- Carbonylation88
Lingua
- eng28612
- ita6840
- fre287
- spa245
- ger96
- grc23
- alb18
- por16
- tur12
- lat10
Accesso al fulltext
- no fulltext39874
- open457
- reserved44
- restricted21
- internalNetwork5
- embargoed1
- partially open1